In the Media
Are you looking for the latest media coverage of the BioMed X, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
BioMed X and Servier Launch First XSeed Labs in Europe
PHARMA FOCUS EUROPE
BioMed X and Servier launch AI-powered antibody research at New XSeed Labs in Paris-Saclay
Indian Pharma Post
BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design
Pharmafile
BioMed X and Boehringer Ingelheim are expanding their joint XSeed Labs incubator in Ridgefield, Connecticut, with the launch of a second research group focused on next-generation intraocular biologics
Labmate Online
BioMed X and Boehringer Ingelheim expand joint XSeed labs incubator in the US
BioSpectrum Asia
BioMed X and Boehringer Ingelheim Expand Joint XSeed Labs Incubator in the U.S.
FirstWord PHARMA
BioMed X expands with Boehringer Ingelheim to join the combined XSeed Labs incubator in the United States
等信源发布
The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
Manager.bg
BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
Thansettakij
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Sina Finance
Global race to lure us researchers intensifies after Trump cuts
Bloomberg